Related Experiment Video
Updated: May 25, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Sample size re-estimation for survival data in clinical trials with an adaptive design
1Clinical Statistics, Pfizer Japan Inc., Tokyo, Japan. kanae.togo@pfizer.com
Pharmaceutical Statistics
|February 14, 2012
Summary
This study introduces a new method for adjusting sample size in clinical trials with survival data. It addresses potential issues with interim hazard estimates to ensure accurate sample size re-estimation.
Area of Science:
- Clinical Trials
- Biostatistics
- Survival Analysis
Background:
- Sample size re-estimation is crucial in ongoing clinical trials with survival data.
- Standard methods using interim hazard estimates can be unreliable due to chance variations.
- Mutual dependence of data in survival trials complicates interim analysis sample size calculations.
Purpose of the Study:
- To propose a novel interim hazard ratio estimate for accurate sample size re-estimation in survival data clinical trials.
- To address the type-I error rate inflation associated with sample size re-estimation.
- To evaluate the impact of the Weibull distribution's shape parameter on sample size adjustments.
Main Methods:
- Development of a new interim hazard ratio estimation method for sample size re-estimation.
- Validation through simulation studies.
- Demonstration using an actual clinical trial dataset.
Main Results:
- The proposed interim hazard ratio estimate provides a more robust approach to sample size re-estimation.
- The method effectively mitigates issues arising from chance fluctuations in interim hazard estimates.
- The influence of the Weibull shape parameter on sample size re-estimation was quantified.
Conclusions:
- The proposed method offers a reliable solution for sample size re-estimation in survival data clinical trials.
- Accurate sample size adjustments are essential for maintaining trial integrity and statistical power.
- This approach enhances the precision of sample size calculations during interim analyses.
Related Concept Videos
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:18Survival Curves
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...